Sio Capital Management’s Aligos Therapeutics ALGS Stock Holding History

Sio Capital Management’s Portfolio ALGS Stock Details ALGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.89M	Hold	327,237	–	–	0.31%	47
2026 Q1	$2.43M	Sell	327,237 -8,700	-3%	-$66K	0.35%	53
2025 Q4	$3.13M	Hold	335,937	–	–	0.49%	42
2025 Q3	$3.29M	Hold	335,937	–	–	0.83%	31
2025 Q2	$2.42M	Buy	335,937 +155,217	+86%	+$929K	0.93%	28
2025 Q1	$1.49M	Buy	+180,720	New	+$3.96M	0.44%	38

Other funds holding ALGS

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sio Capital Management's ALGS Position: Q2 2026 in Review

Sio Capital Management held its Aligos Therapeutics (ALGS) position steady in Q2 2026 at 327,237 shares worth $1.89M. The position accounts for 0.31% of the portfolio, ranked #47.

Sio Capital Management first reported a position in ALGS in Q1 2025 and has held it in 6 quarters since. The position peaked at $3.29M in Q3 2025. 31 funds tracked by Wall St. Rank hold ALGS as of Q2 2026.

Sio Capital Management held 327,237 shares of Aligos Therapeutics worth $1.89M as of Q2 2026.
Sio Capital Management left its Aligos Therapeutics share count unchanged in Q2 2026.
Aligos Therapeutics made up 0.31% of Sio Capital Management's portfolio in Q2 2026, its #47 holding.
Sio Capital Management first reported a position in Aligos Therapeutics in Q1 2025 and has held it in 6 quarters since.
Sio Capital Management's Aligos Therapeutics position peaked at $3.29M in Q3 2025.
31 funds tracked by Wall St. Rank held Aligos Therapeutics as of Q2 2026.

Based on Sio Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.